- Exchange: JASDAQ
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Services
- Sub-Industry: Medical Labs&Testing Srv
Company Profile for tella Inc (2191)
tella, Inc. provides cancer treatment and know-hows to contracted medical institutions. The company supports these medical institutions by offering dendritic cell vaccine treatment and other technology that chemical therapy and actinotherapy combined.
Contact Information
tella Inc
4-7-2 Kojimachi
Chiyoda-ku
Tokyo, 102-0083
Japan
Key Executives for tella Inc (2191)
| Yuichiro YazakiPresident/Founder | Naoko IinoDirector |
| Ryohei YamamotoDirector | Hideki MatsubaraDirector |
| Yoshikazu YonemitsuDirector |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page